BURHIGH SIGNALFINANCIAL10-K

Burford Capital experienced substantially lower profitability with net income declining meaningfully year-over-year while increasing debt levels and expanding balance sheet obligations.

The company's core profitability metrics showed significant deterioration, with operating income declining by over 40% and net income falling substantially, suggesting weaker performance in the legal finance portfolio or timing issues with case resolutions. Despite the earnings decline, the company maintained strong liquidity with increased cash balances, though this came alongside notably higher debt levels.

Comparing 2026-02-26 vs 2025-03-03View on EDGAR →
FINANCIAL ANALYSIS

Burford's financial performance weakened considerably with revenue declining 24% and both operating income and net income falling substantially compared to the prior year. The balance sheet expanded meaningfully, with total liabilities increasing over 20% and debt rising to $2.1 billion, though cash reserves also grew to $566 million, maintaining reasonable liquidity. The combination of declining profitability and increased leverage suggests either challenging market conditions for legal finance or significant timing effects in case settlements that warrant close investor monitoring.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
-57.3%
$146.5M$62.6M

Net income declined 57.3% — review whether driven by operations, interest costs, or non-recurring items.

Capital Expenditure
Cash Flow
-57%
$661K$284K

Capex reduced 57% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Operating Income
P&L
-40.6%
$390.6M$232.1M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Revenue
P&L
-24.3%
$546.1M$413.4M

Revenue softened 24.3% — monitor whether this is cyclical or structural.

Total Debt
Balance Sheet
+20.7%
$1.8B$2.1B

Debt rose 20.7% — additional borrowing for investment or operations; monitor coverage ratios.

Cash & Equivalents
Balance Sheet
+20.5%
$469.9M$566.4M

Cash grew 20.5% — improving liquidity position supports investment and shareholder returns.

Total Liabilities
Balance Sheet
+20.4%
$2.9B$3.5B

Liabilities increased 20.4% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-03-03
ADDED
As of February 19, 2026 , there were 218,897,440 ordinary shares outstanding.
Management's discussion and analysis of financial condition and results of operations 41 Statements of operations and Statements of financial condition 43 Fair value of capital provision assets and Undrawn commitments 48 Segments 50 Liquidity and capital resources and Off-balance sheet arrangements 64 Critical accounting estimates and Reconciliations 67 Item 7A.
T a b l e o f C o n t e n t s Burford-only (non-GAAP) A basis of presentation that refers to assets, liabilities and activities that pertain only to Burford on a proprietary basis, excluding any third-party interests and the portions of jointly owned entities owned by others.
Deployment Financing provided for an asset or other additions on consolidation, which add to our deployed cost in such asset.
EP Funds Eton Park Fund LP, Eton Park Overseas Fund Limited and Eton Park Master Fund Limited are entities that are plaintiffs in the YPF matter and with which we have a variety of relationships and entitlements.
+7 more — sign up free →
REMOVED
As of February 24, 2025 , there were 219,421,904 ordinary shares outstanding.
Management's discussion and analysis of financial condition and results of operations 43 Item 7A.
Deployment Financing provided for an asset, which adds to our deployed cost in such asset.
Legal risk management Relates to matters where we provide some form of legal risk arrangement, such as an indemnity or insurance for adverse legal costs.
At the date of this annual report, our post settlement activity occurs primarily in COLP, BAIF and BAIF II.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →